expressbpdAugust 04, 2017
Tag: lupin , FDA Approval , Rosuvastatin Calcium tablets
Lupin has received final approval for Rosuvastatin Calcium Tablets 5 mg, 10 mg, 20 mg and 40 mg from the United States Food and Drug Administration (FDA) to market a generic version of iPR Pharmaceuticals’ Crestor tablets.
Lupin’s Rosuvastatin calcium tablets 5 mg, 10 mg, 20 mg and 40 mg is the AB rated generic equivalent of iPR Pharmaceuticals’ Crestor tablets. The medicine is indicated for the treatment of adult patients with hypertriglyceridemia, primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) and adult patients with homozygous familial hypercholesterolemia.
Previous:FDA Approves Mavyret
Next:The Vaccine Debate
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: